Pimyupa Manaswiyoungkul

80 St. George Street
Toronto, ON M5S3H6, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Acetylation of Axonal G3BP1 through ELP3 Accelerates Axon Regeneration.

Acetylation of Axonal G3BP1 through ELP3 Accelerates Axon Regeneration.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma.

High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 16, 2022

Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma.

Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma.

Journal: Journal of medicinal chemistry

Published: February 04, 2022

Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.

Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.

Journal: EMBO molecular medicine

Published: September 28, 2021

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia.

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia.

Journal: Journal of medicinal chemistry

Published: June 08, 2021

Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype.

Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype.

Journal: Journal of medicinal chemistry

Published: February 12, 2021

Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting.

Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting.

Journal: Journal of medicinal chemistry

Published: July 17, 2020

PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.

PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.

Journal: European journal of medicinal chemistry

Published: March 02, 2020

Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.

Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.

Journal: ACS medicinal chemistry letters

Published: October 13, 2019

Targeting prenylation inhibition through the mevalonate pathway.

Targeting prenylation inhibition through the mevalonate pathway.

Journal: RSC medicinal chemistry

Published: September 16, 2019

Optimization of a high-throughput fluorescence polarization assay for STAT5B DNA binding domain-targeting inhibitors.

Optimization of a high-throughput fluorescence polarization assay for STAT5B DNA binding domain-targeting inhibitors.

Journal: Journal of pharmaceutical and biomedical analysis

Published: September 05, 2019

Structural and functional consequences of the STAT5BN642H driver mutation.

Structural and functional consequences of the STAT5BN642H driver mutation.

Journal: Nature communications

Published: September 30, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026